CVE-2022-2135
Advantech iView
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized attacker to disclose information.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Advantech iView
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized attacker to disclose information.
- Record
CVE-2022-2135- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
EUVDEUVD-2022-34420
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized attacker to disclose information.
- Record
EUVD-2022-34420- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-p352-52vf-m6c4
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized...
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized attacker to disclose information.
- Record
GHSA-p352-52vf-m6c4- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
NVD
The affected product is vulnerable to multiple SQL injections, which may allow an unauthorized attacker to disclose information.
- Record
CVE-2022-2135- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-2135 is a high vulnerability (CVSS 7.5) in Advantech Iview, published July 22, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 10.5%, the 95th percentile. No source names a fixed version.